• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Rapid response to recombinant interferon alpha 2B and high-dose prednisone in multiple drug-resistant multiple myeloma.

作者信息

Wahlin A, Holm J

机构信息

Department of Medicine, University Hospital Umeå, Sweden.

出版信息

Eur J Haematol. 1989 Oct;43(4):352-4. doi: 10.1111/j.1600-0609.1989.tb00313.x.

DOI:10.1111/j.1600-0609.1989.tb00313.x
PMID:2583262
Abstract
摘要

相似文献

1
Rapid response to recombinant interferon alpha 2B and high-dose prednisone in multiple drug-resistant multiple myeloma.
Eur J Haematol. 1989 Oct;43(4):352-4. doi: 10.1111/j.1600-0609.1989.tb00313.x.
2
Interferon-alpha 2b added to melphalan-prednisone for initial and maintenance therapy in multiple myeloma. A randomized, controlled trial. The Nordic Myeloma Study Group.α-干扰素2b联合美法仑-泼尼松用于多发性骨髓瘤的初始及维持治疗。一项随机对照试验。北欧骨髓瘤研究组
Ann Intern Med. 1996 Jan 15;124(2):212-22. doi: 10.7326/0003-4819-124-2-199601150-00004.
3
Recombinant interferon-alpha combined with prednisone in metastatic renal cell carcinoma. Reduced toxicity without reduction of the response rate--a phase II study.重组干扰素α联合泼尼松治疗转移性肾细胞癌。毒性降低但缓解率未降——一项II期研究
Cancer. 1990 Jun 1;65(11):2451-4. doi: 10.1002/1097-0142(19900601)65:11<2451::aid-cncr2820651108>3.0.co;2-3.
4
Experience with poorly myelosuppressive chemotherapy schedules for advanced myeloma. The Cooperative Group of Study and Treatment of Multiple Myeloma.晚期骨髓瘤低骨髓抑制化疗方案的经验。多发性骨髓瘤研究与治疗协作组。
Br J Cancer. 1996 Mar;73(6):794-7. doi: 10.1038/bjc.1996.138.
5
A randomized clinical trial comparing melphalan/prednisone with or without interferon alfa-2b in newly diagnosed patients with multiple myeloma: a Cancer and Leukemia Group B study.一项比较美法仑/泼尼松联合或不联合干扰素α-2b用于新诊断的多发性骨髓瘤患者的随机临床试验：癌症与白血病B组研究
J Clin Oncol. 1993 Jan;11(1):155-60. doi: 10.1200/JCO.1993.11.1.155.
6
VMCP chemotherapy with or without interferon-alpha-2 in newly diagnosed patients with multiple myeloma.
Onkologie. 1989 Feb;12(1):27-9. doi: 10.1159/000216593.
7
Complete remission induction with combined VBMCP chemotherapy and interferon (rIFN alpha 2b) in patients with multiple myeloma.采用联合VBMCP化疗和干扰素（重组干扰素α 2b）诱导多发性骨髓瘤患者达到完全缓解
Leuk Lymphoma. 1996 Feb;20(5-6):447-52. doi: 10.3109/10428199609052427.
8
Interferon therapy during the plateau phase of multiple myeloma: an update of the Swedish study.多发性骨髓瘤平台期的干扰素治疗：瑞典研究的最新进展。
Eur J Cancer. 1991;27 Suppl 4:S45-8. doi: 10.1016/0277-5379(91)90571-t.
9
Alpha-2-interferon/melphalan/prednisone in previously untreated patients with multiple myeloma: a phase I-II trial.α-2干扰素/美法仑/泼尼松用于既往未经治疗的多发性骨髓瘤患者：一项I-II期试验
Cancer Treat Rep. 1986 Apr;70(4):473-6.
10
Effect of interferon on the health-related quality of life of multiple myeloma patients: results of a Nordic randomized trial comparing melphalan-prednisone to melphalan-prednisone + alpha-interferon. The Nordic Myeloma Study Group.
Br J Haematol. 1996 Aug;94(2):324-32. doi: 10.1046/j.1365-2141.1996.d01-1802.x.

引用本文的文献

1
Long-term therapy with recombinant human erythropoietin (rHu-EPO) in progressing multiple myeloma.重组人促红细胞生成素（rHu-EPO）用于进展性多发性骨髓瘤的长期治疗。
Ann Hematol. 1995 Jun;70(6):313-8. doi: 10.1007/BF01696618.